Showing papers by "Wayne Langholff published in 2010"

PDF

Open Access

Journal Article•DOI•

T1040 Safety of Infliximab and Other Crohn's Disease Therapies: TREAT™ Registry Data With 27, 762 Patient-Years of Follow-up

[...]

Gary R. Lichtenstein, Russell D. Cohen, Brian G. Feagan, Bruce Salzberg, Michelle Turner, David Mink, Wayne Langholff, Delma L. Broussard, Robert H. Diamond, William J. Sandborn - Show less +6 more

01 May 2010-Gastroenterology

TL;DR: IFX or PRED alone conferred a 2-fold increase risk for SI, whereas NARC increased the risk 6-fold, and the highest risk was observed for PRED and NARC together (10-fold) and PRED plus IMM plus NARC (9-fold).

...read moreread less

19 citations

Journal Article•DOI•

Mo1800 Risk Factors for Serious Infections in Elderly Patients Receiving Infliximab and Other Crohn's Disease Therapies: TREAT™Registry Data

[...]

Gary R. Lichtenstein, Wayne Langholff, Brian G. Feagan, Russell D. Cohen, Bruce Salzberg, Jay Popp, R. Nissinen, William J. Sandborn - Show less +4 more

01 May 2010-Gastroenterology

11 citations